Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Suegene K. Lee"'
Autor:
Eric Stahl, Devinder S. Dhindsa, Naga Chalasani, Suegene K. Lee, Pratik B. Sandesara, Laurence S. Sperling
Publikováno v:
Journal of the American College of Cardiology. 73:948-963
Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) are both manifestations of end-organ damage of the metabolic syndrome. Through multiple pathophysiological mechanisms, CVD and NAFLD are associated with each other. Systemic in
Autor:
Danny J. Eapen, Gina Lundberg, Jay Khambhati, Pratik B Sandesara, Suegene K. Lee, Basil Margolis, Neil F. Gordon, Laurence S. Sperling, Barry A. Franklin
Publikováno v:
State of the Art Surgical Coronary Revascularization
Cardiac rehabilitation is a key component of secondary prevention for patients who have undergone coronary artery bypass graft surgery. Cardiac rehabilitation is a comprehensive, multidisciplinary, long-term provision of medical evaluation, prescript
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::379ef99fa8fa557b477f7b0a095117d2
https://doi.org/10.1093/med/9780198758785.003.0024
https://doi.org/10.1093/med/9780198758785.003.0024
Autor:
Wesley T. O'Neal, Pratik B. Sandesara, Kornelia Kotseva, Arash Harzand, Tina Varghese, Dan Gaita, Susan Connolly, Catriona Jennings, Laurence S. Sperling, Suegene K. Lee, Jay Khambhati, Sherry L. Grace, David R. Wood, Devinder S. Dhindsa
Publikováno v:
S239
S231
S231
Atherosclerotic cardiovascular disease (ASCVD) and its associated economic burden are increasing globally. Although cardiac rehabilitation is a vital component of secondary prevention with proven benefits, it is underutilized due to numerous barriers
Autor:
Jay Khambhati, Suegene K. Lee, Nanette K. Wenger, Tina Varghese, Pratik B. Sandesara, Eric Stahl, Sonali Kumar, Laurence S. Sperling
Publikováno v:
Clinical Cardiology. 40:832-838
Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of mortality in women. Historically, medical research has focused on male patients, and subsequently, there has been decreased awareness of the burden of ASCVD in females until
Autor:
Devinder S. Dhindsa, Suegene K. Lee, Arshed A Quyyumi, Jay Khambhati, C Venkata S Ram, Pratik B Sandesara, Bryan Kindya
Publikováno v:
Hypertension Journal. 3:81-88
Autor:
Jay Khambhati, C Venkata S Ram, Suegene K. Lee, Ankit Bhargava, Arshed A Quyyumi, Pratik B Sandesara, Marc C Engels
Publikováno v:
Hypertension Journal. 3:72-80
Publikováno v:
Future Cardiology. 12:497-509
Coronary microvascular disease in the absence of myocardial diseases has traditionally been diagnosed through coronary reactivity testing in the cardiac catheterization laboratory. Compared with invasive procedures, blood-based biomarkers may have re
Publikováno v:
Journal of the Medical Association of Georgia. 105(4)
Autor:
Eric P, Stahl, Devinder S, Dhindsa, Suegene K, Lee, Pratik B, Sandesara, Naga P, Chalasani, Laurence S, Sperling
Publikováno v:
Journal of the American College of Cardiology. 73(8)
Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) are both manifestations of end-organ damage of the metabolic syndrome. Through multiple pathophysiological mechanisms, CVD and NAFLD are associated with each other. Systemic in
Autor:
Pratik B. Sandesara, Mohamad Mazen Gafeer, Ayman Samman Tahhan, Arshed A. Quyyumi, Yi-An Ko, Jonathan H. Kim, Ayman Alkhoder, Suegene K. Lee, Laurence S. Sperling, Peter W.F. Wilson, Agim Beshiri, Muhammad Hammadah, Salim S. Hayek, Leslee J. Shaw, Jay Khambhati, Wesley T. O'Neal, Matthew L. Topel, Gillian Murtagh, Stephen E. Epstein
Publikováno v:
The American journal of cardiology. 121(12)
It is unknown whether the association of high-sensitivity troponin I (hs-TnI) with adverse cardiovascular outcomes varies by the presence of chronic kidney disease (CKD). We examined the association of hs-TnI with adverse cardiovascular outcomes in t